Diabetes MellitusJohn A. Galloway, Janet H. Potvin, Charles R. Shuman Lilly Research Laboratories, 1988 - 335 pages |
From inside the book
Results 1-3 of 79
Page 124
... treatment was with mixed beef - pork unchromatographed insulin . After three months of treatment , she noted allergy and insulin lipoat- rophy at the injection site and at sites where insulin had not been injected . On August 16 , 1979 ...
... treatment was with mixed beef - pork unchromatographed insulin . After three months of treatment , she noted allergy and insulin lipoat- rophy at the injection site and at sites where insulin had not been injected . On August 16 , 1979 ...
Page 321
... treatment of lactic acidosis , 270 plasma concentration and ketoacidosis , 261-262 Biguanides , 55 , 148-149 ... treatment of diabetic nephropathy , 293 Carbamazepine , in treatment of diffuse symmetrical polyneuropathy in diabetes , 295 ...
... treatment of lactic acidosis , 270 plasma concentration and ketoacidosis , 261-262 Biguanides , 55 , 148-149 ... treatment of diabetic nephropathy , 293 Carbamazepine , in treatment of diffuse symmetrical polyneuropathy in diabetes , 295 ...
Page 325
... treatment , 152-154 use of glyburide in , 148 , 153 use of insulin in , 153-154 use of sulfonylurea agents in , 148 ... treatment of , 288 classification , 283-284 clofibrate in treatment of , 288 diagnosis , 281-282 diet in treatment of ...
... treatment , 152-154 use of glyburide in , 148 , 153 use of insulin in , 153-154 use of sulfonylurea agents in , 148 ... treatment of , 288 classification , 283-284 clofibrate in treatment of , 288 diagnosis , 281-282 diet in treatment of ...
Contents
Definition | 1 |
Chapter 2 iabetes Mellitus and Heredity | 15 |
Chapter 3 athophysiology of Diabetes Mellitus | 27 |
Copyright | |
15 other sections not shown
Common terms and phrases
abnormalities action activity agents antibodies associated betes blood glucose blood glucose concentrations body carbohydrate cause cells changes Chapter clinical complications continuous daily decrease determinations diabetes mellitus diabetic diet diabetic ketoacidosis diagnosis diet disease dose early effect exercise factors Figure given glucose tolerance glycemic glycosylated hemoglobin hormone human insulin hypoglycemia impaired important improved increased indicated individuals initial injection insulin infusion insulin receptor insulin resistance insulin secretion insulin therapy insulin-dependent levels lipoprotein liver meals measure metabolic methods mg/dl mmol/L monitoring muscle myocardial infarction needed normal obese occur oral patients with diabetes patients with Type plasma glucose pregnancy prevent production protein pump receptor reduced regular renal reported response retinopathy risk severe Source studies subcutaneous subjects Table therapy tion tissue treated treatment Type I diabetes Type II units urine usually values weight